Results 141 to 150 of about 595,334 (253)
Despite the progress in fighting against infectious diseases of bacterial origin, the incidence of generalized forms of meningococcal infection (GFMI) remains a topical public health problem not only in countries with historical high incidence, but also ...
M. V. Abramtseva+2 more
doaj
Meningococcal conjugate vaccines: optimizing global impact
Andrew Terranella1,2, Amanda Cohn2, Thomas Clark2 1Epidemic Intelligence Service, Division of Applied Sciences, Scientific Education and Professional Development Program Office, 2Meningitis and Vaccine Preventable Diseases Branch, National Center for ...
Terranella A, Cohn A, Clark T
doaj
Introduction Individuals with immunocompromising conditions (e.g. asplenia, complement deficiency, HIV infection) or with high exposure to Neisseria meningitidis (e.g.
Shravani Bobde+3 more
doaj +1 more source
In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology,
R. Gasparini+7 more
doaj +1 more source
Meningococcal vaccine and herd immunity [PDF]
Stelios Sbyrakis, Emmanouil Galanakis
openalex +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 9, Issue S1, June 2025.
wiley +1 more source
Change in Recommendation for Meningococcal Vaccine for Travelers [PDF]
openalex +1 more source
Meningococcal B vaccination : a novel approach [PDF]
Meningococcal B disease is associated with a mortality of up to 10% and significant morbidity in survivors. Attempts to produ.ce an effective vaccine based on established methods over several decades, have succeeded in designing vaccines suitable only ...
Attard Montalto, Simon
core